Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Brogan discusses the various opportunities and challenges that have accompanied recent evolutions in inflammatory bowel disease management.

Access, Affordability, and Innovation in IBD Care, With Jamie Brogan, NP

Brogan explains how to navigate the complexities of the Crohn’s disease treatment landscape and why patients need to be included in the decision making process.

Shared Decision Making in Crohn’s Disease Management, With Jamie Brogan, NP

From clinical trial updates in IBD to novel research about IBS and other disorders of gut brain interaction, catch up on the latest headlines in GI.

7 Gastroenterology Headlines You Missed in July 2025

Patients and clinicians perceived a gap that largely didn't exist in views on diet's role in IBD.

Gap Persists in Patient-Clinician Communication Despite Similar Views on Diet’s Role in IBD

Sands describes the current landscape of Crohn’s disease therapies and reviews GALAXI 2 and 3 data supporting guselkumab’s role in evolving care paradigms.

GALAXI Findings and Guselkumab’s Role in Crohn’s Disease Care, with Bruce Sands, MD

Anti-TNF therapies show strong 3-year durability in pediatric IBD, with new clinical markers helping predict early nonresponse in Crohn’s disease and UC/IBD-unclassified cases.

Study Identifies Predictors of Anti-TNF Nonresponse in Pediatric IBD

Positive topline results showed obefazimod met its primary endpoint for clinical remission at week 8 in the 50 mg dose cohort in ABECT-1 and ABECT-2.

Obefazimod Meets Primary Endpoint in Phase 3 ABECT Program for Ulcerative Colitis

The first half of 2025 recap for gastroenterology spotlights GI FDA approvals, clinical trial data, and new guidance on bowel preparation for colonoscopy.

Gastroenterology First Half Recap: 2025

Immunization is underused in IBD care despite high infection risks from immunosuppressants—early, proactive vaccination is essential for prevention.

Strategic Immunization in IBD: A Clinical Priority Amidst Rising Infection Risks

Point-of-care intestinal ultrasound offers real-time, noninvasive monitoring for pediatric IBD, enabling faster, personalized treatment decisions in routine care.

Faster, Targeted Pediatric IBD Care with Point-of-Care Ultrasound

On the HCPLive inflammatory bowel disease page, resources on the topics of medical news and expert insight into IBD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBD and more.

Inflammatory Bowel Disease